Literature DB >> 29172450

Endogenous Alpha-Synuclein Protein Analysis from Human Brain Tissues Using Single-Molecule Pull-Down Assay.

Goun Je1, Benjamin Croop2, Sambuddha Basu1, Jialei Tang2, Kyu Young Han2, Yoon-Seong Kim1.   

Abstract

Alpha-synuclein (α-SYN) is a central molecule in Parkinson's disease pathogenesis. Despite several studies, the molecular nature of endogenous α-SYN especially in human brain samples is still not well understood due to the lack of reliable methods and the limited amount of biospecimens. Here, we introduce α-SYN single-molecule pull-down (α-SYN SiMPull) assay combined with in vivo protein crosslinking to count individual α-SYN protein and assess its native oligomerization states from biological samples including human postmortem brains. This powerful single-molecule assay can be highly useful in diagnostic applications using various specimens for neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29172450     DOI: 10.1021/acs.analchem.7b04335

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  3 in total

1.  Facile single-molecule pull-down assay for analysis of endogenous proteins.

Authors:  Benjamin Croop; Kyu Young Han
Journal:  Phys Biol       Date:  2019-03-22       Impact factor: 2.959

Review 2.  Single molecule imaging of protein aggregation in Dementia: Methods, insights and prospects.

Authors:  John S H Danial; David Klenerman
Journal:  Neurobiol Dis       Date:  2021-03-09       Impact factor: 5.996

3.  Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease.

Authors:  Derya Emin; Yu P Zhang; Evgeniia Lobanova; Alyssa Miller; Xuecong Li; Zengjie Xia; Helen Dakin; Dimitrios I Sideris; Jeff Y L Lam; Rohan T Ranasinghe; Antonina Kouli; Yanyan Zhao; Suman De; Tuomas P J Knowles; Michele Vendruscolo; Francesco S Ruggeri; Franklin I Aigbirhio; Caroline H Williams-Gray; David Klenerman
Journal:  Nat Commun       Date:  2022-09-20       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.